Hemoflow: Ingredient Overview, Hematocrit Health Claims & Safety Considerations
The claim that 95% of people have hematocrit issues is hyperbole used to sell a supplement. While hydration and monitoring are vital for those on TRT, Hemo Flow is a commercial product whose ingredients lack clinical proof for reducing hematocrit.
The claim that 95% of people have hematocrit issues is hyperbole used to sell a supplement. While hydration and monitoring are vital for those on TRT, Hemo Flow is a commercial product whose ingredients lack clinical proof for reducing hematocrit.
🔥Hot Take:
- The 95% statistic is total fiction designed to scare you into a checkout cart. 🛒
- While Nattokinase and VasoDrive-AP have heart benefits, they don't 'contain' hematocrit levels like a magic shield. 🛡️
🔥Hot Take:
- •The 95% statistic is total fiction designed to scare you into a checkout cart. 🛒
- •While Nattokinase and VasoDrive-AP have heart benefits, they don't 'contain' hematocrit levels like a magic shield. 🛡️
Claim Breakdown
🎯 Truth Rating: False - Grade F
📝 Why: There is no epidemiological evidence suggesting a 95% prevalence of hematocrit abnormalities. In the general population, hematocrit issues are typically secondary to specific conditions like anemia or polycythemia, rather than a near-universal affliction.
🔗 Source:
•
NCBI: Hemoglobin and Hematocrit- Clinical textbook defining erythrocytosis and anemia as specific medical states, not a default state for 95% of humans.
•
MedlinePlus: Hematocrit- Defines normal ranges (approx. 36-50%) and notes that high/low levels are linked to specific pathologies, not the vast majority of the population.
IMPORTANT WARNING
Disclaimer: This tool provides general informational content and is not a substitute for personalised, professional advice.